PREDILIFE SA (ALPRE.PA) Fundamental Analysis & Valuation

EPA:ALPRE • FR0010169920

Current stock price

3.08 EUR
-0.01 (-0.32%)
Last:

This ALPRE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALPRE.PA Profitability Analysis

1.1 Basic Checks

  • ALPRE had negative earnings in the past year.
  • ALPRE had a negative operating cash flow in the past year.
  • ALPRE had negative earnings in each of the past 5 years.
  • ALPRE had a negative operating cash flow in each of the past 5 years.
ALPRE.PA Yearly Net Income VS EBIT VS OCF VS FCFALPRE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • The Return On Assets of ALPRE (-290.42%) is worse than 95.00% of its industry peers.
Industry RankSector Rank
ROA -290.42%
ROE N/A
ROIC N/A
ROA(3y)-115.89%
ROA(5y)-97.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALPRE.PA Yearly ROA, ROE, ROICALPRE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • ALPRE has a better Gross Margin (98.10%) than 96.25% of its industry peers.
  • In the last couple of years the Gross Margin of ALPRE has grown nicely.
  • The Profit Margin and Operating Margin are not available for ALPRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.18%
GM growth 5Y8.21%
ALPRE.PA Yearly Profit, Operating, Gross MarginsALPRE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALPRE.PA Health Analysis

2.1 Basic Checks

  • ALPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALPRE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALPRE has been increased compared to 5 years ago.
  • The debt/assets ratio for ALPRE is higher compared to a year ago.
ALPRE.PA Yearly Shares OutstandingALPRE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALPRE.PA Yearly Total Debt VS Total AssetsALPRE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -38.95, we must say that ALPRE is in the distress zone and has some risk of bankruptcy.
  • ALPRE has a worse Altman-Z score (-38.95) than 88.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -38.95
ROIC/WACCN/A
WACC6.59%
ALPRE.PA Yearly LT Debt VS Equity VS FCFALPRE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • ALPRE has a Current Ratio of 0.45. This is a bad value and indicates that ALPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALPRE's Current ratio of 0.45 is on the low side compared to the rest of the industry. ALPRE is outperformed by 86.25% of its industry peers.
  • ALPRE has a Quick Ratio of 0.45. This is a bad value and indicates that ALPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALPRE's Quick ratio of 0.45 is on the low side compared to the rest of the industry. ALPRE is outperformed by 83.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
ALPRE.PA Yearly Current Assets VS Current LiabilitesALPRE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALPRE.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.51% over the past year.
  • Looking at the last year, ALPRE shows a very strong growth in Revenue. The Revenue has grown by 134.19%.
  • The Revenue has been growing by 84.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.88%
Revenue 1Y (TTM)134.19%
Revenue growth 3Y51.41%
Revenue growth 5Y84.77%
Sales Q2Q%148.77%

3.2 Future

  • ALPRE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.92% yearly.
  • The Revenue is expected to grow by 116.42% on average over the next years. This is a very strong growth
EPS Next Y-10.83%
EPS Next 2Y-12.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50.7%
Revenue Next 2Y51.3%
Revenue Next 3Y161.34%
Revenue Next 5Y116.42%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALPRE.PA Yearly Revenue VS EstimatesALPRE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
ALPRE.PA Yearly EPS VS EstimatesALPRE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALPRE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALPRE. In the last year negative earnings were reported.
  • Also next year ALPRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALPRE.PA Price Earnings VS Forward Price EarningsALPRE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALPRE.PA Per share dataALPRE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALPRE's earnings are expected to decrease with -12.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALPRE.PA Dividend Analysis

5.1 Amount

  • No dividends for ALPRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALPRE.PA Fundamentals: All Metrics, Ratios and Statistics

PREDILIFE SA

EPA:ALPRE (3/31/2026, 7:00:00 PM)

3.08

-0.01 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners47.25%
Ins Owner ChangeN/A
Market Cap12.10M
Revenue(TTM)728.10K
Net Income(TTM)-3.80M
Analysts86.67
Price Target21.34 (592.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-1.58
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.19
BVpS-1.48
TBVpS-1.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -290.42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.1%
FCFM N/A
ROA(3y)-115.89%
ROA(5y)-97.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.18%
GM growth 5Y8.21%
F-Score2
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -38.95
F-Score2
WACC6.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.93%
Cap/Sales(5y)11.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.88%
EPS Next Y-10.83%
EPS Next 2Y-12.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)134.19%
Revenue growth 3Y51.41%
Revenue growth 5Y84.77%
Sales Q2Q%148.77%
Revenue Next Year50.7%
Revenue Next 2Y51.3%
Revenue Next 3Y161.34%
Revenue Next 5Y116.42%
EBIT growth 1Y17.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.01%
OCF growth 3YN/A
OCF growth 5YN/A

PREDILIFE SA / ALPRE.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PREDILIFE SA?

ChartMill assigns a fundamental rating of 2 / 10 to ALPRE.PA.


What is the valuation status for ALPRE stock?

ChartMill assigns a valuation rating of 0 / 10 to PREDILIFE SA (ALPRE.PA). This can be considered as Overvalued.


Can you provide the profitability details for PREDILIFE SA?

PREDILIFE SA (ALPRE.PA) has a profitability rating of 1 / 10.


What is the financial health of PREDILIFE SA (ALPRE.PA) stock?

The financial health rating of PREDILIFE SA (ALPRE.PA) is 0 / 10.


Can you provide the expected EPS growth for ALPRE stock?

The Earnings per Share (EPS) of PREDILIFE SA (ALPRE.PA) is expected to decline by -10.83% in the next year.